Regenerative Patch Technologies Marks Phase IIb Trial Progress for Macular Degeneration Treatment Regenerative Patch Technologies has treated its first two patients in a Phase IIb clinical trial aimed at improving vision for advanced dry age-related macular degeneration. This trial follows promising Phase I results.

Regenerative Patch Technologies Marks Phase IIb Trial Progress for Macular Degeneration Treatment #USA #Clinical_Trial #Menlo_Park,_California #Regenerative_Patch #RPE_Cell_Implant